DHC (Diversified Healthcare Trust) 5-Year EBITDA Growth Rate: -24.20% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHC Diversified Healthcare Trust DHC
54 GF Score
Price $8.96
GF Value $3.20
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Diversified Healthcare Trust 5-Year EBITDA Growth Rate?

Diversified Healthcare Trust DHC +0.96% 54 5-Year EBITDA Growth Rate is -24.20% as of Mar. 2026. GuruFocus rates DHC with a GF Score™ of 54/100 and a GF Value™ of $3.20 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Diversified Healthcare Trust's EBITDA per Share for the three months ended in Mar. 2026 was $0.24.

During the past 12 months, Diversified Healthcare Trust's average EBITDA Per Share Growth Rate was -61.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -30.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -24.20% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -13.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Diversified Healthcare Trust was 11.60% per year. The lowest was -40.70% per year. And the median was -0.30% per year.


Diversified Healthcare Trust  (NAS:DHC) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Diversified Healthcare Trust 5-Year EBITDA Growth Rate Related Terms


DHC vs LTC, MPT, NHP: 5-Year EBITDA Growth Rate Comparison

For the REIT - Healthcare Facilities subindustry, Diversified Healthcare Trust's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diversified Healthcare Trust 5-Year EBITDA Growth Rate vs REITs Industry

For the REITs industry and Real Estate sector, Diversified Healthcare Trust's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Diversified Healthcare Trust's 5-Year EBITDA Growth Rate falls into.


DHC
54GF Score
Diversified Healthcare Trust DHC
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diversified Healthcare Trust 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of -24.20% mean?
Diversified Healthcare Trust (DHC) has a 5-Year EBITDA Growth Rate of -24.20% as of Mar. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Diversified Healthcare Trust and its competitors.
Is Diversified Healthcare Trust's 5-Year EBITDA Growth Rate too high?
Diversified Healthcare Trust's current 5-Year EBITDA Growth Rate is -24.20%. Overall, Diversified Healthcare Trust has a GF Score™ of 54/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Diversified Healthcare Trust's 5-Year EBITDA Growth Rate compare to LTC and MPT?
Diversified Healthcare Trust's 5-Year EBITDA Growth Rate of -24.20% can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a REITs company?
A good 5-Year EBITDA Growth Rate depends on the REITs industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Diversified Healthcare Trust and its competitors. Diversified Healthcare Trust's current 5-Year EBITDA Growth Rate is -24.20%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diversified Healthcare Trust stock overvalued right now?
Based on GuruFocus' analysis, Diversified Healthcare Trust (DHC) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.20, compared to a current price of $8.96 — trading 179.8% above its estimated fair value. The current 5-Year EBITDA Growth Rate is -24.20%. Diversified Healthcare Trust's overall GF Score™ is 54/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Diversified Healthcare Trust (DHC), the current 5-Year EBITDA Growth Rate is -24.20% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Diversified Healthcare Trust (DHC) Overvalued in 2026?

Based on GuruFocus' analysis, Diversified Healthcare Trust stock appears to be overvalued. The current stock price of $8.96 is trading 179.8% above its estimated GF Value™ of $3.20. GuruFocus considers Diversified Healthcare Trust to be Significantly Overvalued.

Key valuation signals for DHC:

  • 5-Year EBITDA Growth Rate: -24.20%
  • GF Value™: $3.20 vs. price of $8.96 (179.8% above fair value)
  • GF Score™: 54/100 with 7 warning signs

No single metric tells the full story. See the DHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Diversified Healthcare Trust Business Description

Industry Real EstateREITs
Other Exchanges SNF:Germany
Address 255 Washington Street, Suite 300, Two Newton Place, Newton, MA, USA, 02458-1634
Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. The company has two reportable segments: SHOP (Senior Housing Operating Portfolio) and Medical Office and Life Science Portfolio. The SHOP segment includes managed senior living communities providing residential living and care services. The Medical Office and Life Science Portfolio segment consists of properties leased to medical providers and biotechnology laboratories. It generates the majority of its revenue from the SHOP segment.
54GF Score

Get the complete analysis for DHC

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.96
Price
$3.20
GF Value